• Quotes
  • Shortcuts
The Executive's Internet
Tues, June 25th
editor corner icon Editor's Corner | Archive
Still Avoiding Online Reviews? 4 Tips to Use Them to Your Advantage. Patricia
icon
GoogleAmazonWikipedia
site of the day icon Site of the Day | Archive
Unforgettable Last Sentences in Fiction
A book's final lines can make or break the experience. Here are some of the best.


spacerspacer

 

 BUSINESS/FINANCE NEWS
Setup News Ticker
   BUSINESS/FINANCE NEWS
Searching for 'Deal'. (Return)

Google Business NewsJun 25, 2019
Why AbbVie Stock Is Sinking and Allergan Is Soaring Today - Motley Fool
Why AbbVie Stock Is Sinking and Allergan Is Soaring Today  Motley FoolAbbVie looks beyond Humira with a $63 billion deal for Botox-maker Allergan  CNBCAbbVie Strikes Deal to Buy Allergan for About $63 Billion  The Wall Street JournalAllergan stock surges on news that Abbvie will buy Botox maker in a $63 billion deal  Yahoo FinanceBotox Maker Allergan Is Sold to AbbVie in $63 Billion Deal  The New York TimesView full coverage on Google News

RELATED ARTICLES
UPDATE 5-AbbVie looks beyond Humira with $63 bln deal for Botox-maker Allergan (Reuters Company News)

Google Business NewsJun 25, 2019
AbbVie's $63 Billion Mistake - Motley Fool
AbbVie's $63 Billion Mistake  Motley FoolAbbVie looks beyond Humira with a $63 billion deal for Botox-maker Allergan  CNBCAbbVie Strikes Deal to Buy Allergan for About $63 Billion  The Wall Street JournalAllergan stock surges on news that Abbvie will buy Botox maker in a $63 billion deal  Yahoo FinanceBotox Maker Allergan Is Sold to AbbVie in $63 Billion Deal  The New York TimesView full coverage on Google News

RELATED ARTICLES
AbbVie looks beyond Humira with $63 billion deal for Botox-maker Allergan (Reuters Business)

Reuters Company NewsJun 25, 2019
UPDATE 4-AbbVie looks beyond Humira with $63 bln deal for Botox-maker Allergan
Drugmaker AbbVie Inc said on Tuesday it would buy Botox-maker Allergan Plc for about $63 billion, grabbing control of by far the biggest name in medical aesthetics to help reduce its reliance on blockbuster arthritis treatment Humira.

MarketWatchJun 25, 2019
The Fed: Powell says the Fed is ‘grappling' with whether to cut interest rates
Fed Chairman Jerome Powell on Tuesday suggested an interest-rate cut in July was not a done deal.

Google Business NewsJun 25, 2019
Amazon Prime Day 2019: how to find the best deals on TVs and more - The Verge
Amazon Prime Day 2019: how to find the best deals on TVs and more  The VergeAmazon Prime Day will actually be two days this year  CNNPrime Day 2019 - A two-day parade of epic deals.  amazonWindows Central Podcast 138: A new Cortana  Windows CentralAmazon announced the date of Prime Day, and it sounds like Alibaba's Singles Day  Yahoo FinanceView full coverage on Google News

RELATED ARTICLES
Here are the 5 best Amazon Prime Day deals right now (USA Today Money)

MarketWatch MarketPulseJun 25, 2019
Stocks see flat start as investors await remarks by Fed chairman
Stocks opened little changed Tuesday as investors awaited remarks by Federal Reserve Chairman Jerome Powell. The Dow Jones Industrial Average rose 13 points, or less than 0.1%, to 26,740, while the S&P 500 was down less than a point at 2,944. The Nasdaq Composite was off 0.1% at 7,997. Investor expectations for the Federal Reserve to deliver a rate cut as early as next month were boosted after last week's policy meeting and Powell's news conference. Powell will have the opportunity to affirm or soften those expectations when he speaks at 1 p.m. Eastern at the Council on Foreign Relations in New York. Shares of Allergan PLC jumped nearly 29% after agreeing to be bought by fellow drugmaker AbbVie Inc. in a deal valued at $63 billion. Abbvie shares fell 11.5%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.


TRENDING TAGS
FedFedEx Powell Trump government STOCKS
TrumpIran sanctions about Trump-Xi meeting
Tradetensions Iran stocks worries China
stockmarket Fed trade Allergan ahead
marketStock could Fed stocks trade
AllerganAbbVie deal billion maker buy
Stockstrade G20 biggest tensions Iran
AppleCamera Watch iPadOS Cook Facebook
BillionAbbVie deal Allergan buy maker
fundFiler GMO D/A LP SERIES

NEWS SOURCES
Top News (Business News)
Accounting Today
AdWeek News
Banking Business Review
Barron's This Week Magazine
Barron's Up and Down Wall Street Daily
Brad Ideas
Chicago Tribune Business News
CNBC Business
CNBC Economy
CNBC Finance
CNN/Money
CNN/Money Real Estate News
Dismal.com: Analysis
Dismal.com: Indicators
Enterprise Application News
Entrepreneur.com
Forbes Headlines
Forbes Social Media News
FT.com - China, Economy & Trade
FT.com - Financial Markets
FT.com - Hedge Funds
FT.com - Telecoms
FT.com - US
Google Business News
Google Market News
HBS Working Knowledge
Inc.com
INSEAD Knowledge
International Tax Review
Kiplinger
Knowledge@Wharton
L.S. Starrett News
MarketWatch
MarketWatch Breaking News
MarketWatch MarketPulse
McKinsey Quarterly
MSNBC.com: Business
Nielsen Trends
NonProfit Times
NPR Topics: Business
NYTimes Business
OpinionJournal.com
Private Equity Breaking News
Reuters Business
Reuters Company News
Reuters Money
SEC.gov Updates: News Digest
SHRM HR News
Tax Policy News
The Economist International News
The Motley Fool
USA Today Money
Wall Street Journal US Business
Wall Street Transcript
Washington Post Business
WSJ Asia
WSJ Europe
WSJ MoneyBeat
WSJ Opinion
WSJ US News
WSJ World Markets
Yahoo Business
  • CEOExpress
  • 1 Boston Place | Suite 2600
    Boston MA 02108
  • 617 482 1200
    617 299 8649 (fax)
  • Contact
  • As an Amazon Associate
    CEOExpress earns from
    qualifying purchases.

©1999-2019 CEOExpress Company LLC